These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10436409)

  • 1. Oral tumoractivated chemotherapy--an introduction.
    Kaye SB
    Oncology; 1999 Jul; 57 Suppl 1():1. PubMed ID: 10436409
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoropyrimidines: a critical evaluation.
    Brito RA; Medgyesy D; Zukowski TH; Royce ME; Ravandi-Kashani F; Hoff PM; Pazdur R
    Oncology; 1999 Jul; 57 Suppl 1():2-8. PubMed ID: 10436410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine: A new oral fluoropyrimidine.
    Ignoffo RJ
    Cancer Pract; 1998; 6(5):302-4. PubMed ID: 9767352
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of oral chemotherapy agents.
    Birner A
    Clin J Oncol Nurs; 2003; 7(6 Suppl):11-9. PubMed ID: 14705495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine].
    Saeki T; Takashima S
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication sheets for patients. Oral chemotherapy.
    Clin J Oncol Nurs; 2003; 7(6 Suppl):40-72. PubMed ID: 14705499
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine in the treatment of advanced gastric cancer.
    Lee JL; Kang YK
    Future Oncol; 2008 Apr; 4(2):179-98. PubMed ID: 18407732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xeloda in the treatment of metastatic breast cancer.
    Blum JL
    Oncology; 1999 Jul; 57 Suppl 1():16-20. PubMed ID: 10436412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].
    Kato K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003
    [No Abstract]   [Full Text] [Related]  

  • 10. Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.
    Tipples K; Kolluri RB; Raouf S
    J Oncol Pharm Pract; 2009 Dec; 15(4):237-9. PubMed ID: 19276137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral fluoropyrimidines in oncology].
    González Barón M
    An R Acad Nac Med (Madr); 1998; 115(3):721-45; discussion 745-6. PubMed ID: 10208021
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational design of new tumoractivated cytotoxic agents.
    Verweij J
    Oncology; 1999 Jul; 57 Suppl 1():9-15. PubMed ID: 10436411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete response of brain metastases originating in breast cancer to capecitabine therapy.
    Siegelmann-Danieli N; Stein M; Bar-Ziv J
    Isr Med Assoc J; 2003 Nov; 5(11):833-4. PubMed ID: 14650117
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine and docetaxel combination for the treatment of breast cancer.
    Morishita M; Leonard RC
    Womens Health (Lond); 2008 Jan; 4():11-22. PubMed ID: 19072447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
    Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
    Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive results achieved with new oral chemotherapy agent.
    Timmerman D
    Oncol Nurs Forum; 1999 May; 26(4):675. PubMed ID: 10337634
    [No Abstract]   [Full Text] [Related]  

  • 17. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
    Saif MW; Garcon MC; Rodriguez G; Rodriguez T
    In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient.
    Ratain MJ
    J Clin Oncol; 2002 Mar; 20(6):1434-5. PubMed ID: 11896086
    [No Abstract]   [Full Text] [Related]  

  • 19. Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.
    Pentheroudakis G; Pappas P; Golfinopoulos V; Fountzilas G; Nikolaidou M; Boumba VA; Vougiouklakis T; Nikiforidis L; Tzamakou E; Siarabi O; Marselos M; Pavlidis N
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):733-9. PubMed ID: 17333194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine-induced inflammation of actinic keratosis: case report and literature review.
    Stanciu M; Aubut N; Gagné E; Thibeault MM
    J Cutan Med Surg; 2012; 16(5):298-9. PubMed ID: 22971302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.